Smoke-Free Homes Intervention for Smoking Cessation
(SFH 5A RCT Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores a new method to help people quit smoking by integrating a smoke-free homes intervention into standard smoking cessation guidelines. The approach includes interactive mailings and coaching calls to encourage bans on smoking in homes and vehicles. It targets smokers who have had a cigarette in the past 30 days, are connected with a primary care provider in Georgia, and are not part of another quitting program. Researchers will check participants at six and twelve months to confirm smoking cessation using a saliva test. As an unphased trial, this study offers participants a unique opportunity to contribute to innovative smoking cessation strategies.
Do I need to stop my current medications to join the trial?
The trial information does not specify whether you need to stop taking your current medications.
What prior data suggests that the Smoke-Free Homes intervention is safe for smoking cessation?
Research has shown that making homes smoke-free is generally well-received by participants. One study found that when homes are smoke-free, people tend to smoke fewer cigarettes each day, indicating that these interventions are usually safe and can help people quit smoking.
Another study found that people who set smoke-free rules at home tried to quit smoking more often and were less likely to start again, demonstrating more attempts to stop smoking and fewer relapses. Additionally, strong support exists for creating smoke-free environments, indicating that people find this approach acceptable.
Overall, these findings suggest that the Smoke-Free Homes intervention is a safe way to help people stop smoking.12345Why are researchers excited about this trial?
Researchers are excited about the Smoke-Free Homes intervention because it offers a comprehensive approach to smoking cessation by targeting the home environment. Unlike standard treatments that primarily focus on individual behavior change, this intervention involves creating a smoke-free living space and connects participants to quitline support, enhancing accountability and motivation. This dual approach not only helps individuals quit smoking but also protects non-smokers in the household from secondhand smoke, providing a more holistic benefit. By validating outcomes through saliva cotinine levels, the intervention also ensures accurate assessment of smoking cessation, making it a promising alternative to conventional methods.
What evidence suggests that the Smoke-Free Homes intervention is effective for smoking cessation?
Research has shown that the Smoke-Free Homes program helps create smoke-free environments in homes and cars. One study found that more participants in the program reported completely banning smoking in their homes compared to those not in the program, with 30.4% versus 14.9% after three months. Other studies have also found that more participants in the program made their homes smoke-free than those who didn't join. Participants in this trial will receive the expanded Smoke-Free Homes intervention, which has led to bigger drops in daily smoking and more attempts to quit. These results suggest that this program can help smokers quit by encouraging smoke-free living spaces.36789
Who Is on the Research Team?
Michelle Kegler, PhD
Principal Investigator
Emory University
Are You a Good Fit for This Trial?
This trial is for adult smokers referred by a primary care physician from a participating health center in South Georgia, who have smoked recently but aren't in another cessation program. Participants must speak and understand English, be the only person from their household to join, and not be pregnant or unable to consent.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Intervention
Participants receive the Smoke-Free Homes intervention, including interactive mailings and coaching calls, and may connect to the quitline
Follow-up
Participants are monitored for smoking cessation and smoke-free home establishment at six and twelve months
What Are the Treatments Tested in This Trial?
Interventions
- Smoke-Free Homes intervention
- Smoke-Free Homes Intervention
Find a Clinic Near You
Who Is Running the Clinical Trial?
Emory University
Lead Sponsor
Michelle C. Kegler
Lead Sponsor
National Institutes of Health (NIH)
Collaborator
National Cancer Institute (NCI)
Collaborator